Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on March 20, 2020, detailing the execution of a significant $2.0 billion 364-day secured term loan facility, referred to as the "Reserve Liquidity Facility." This facility, entered into on March 19, 2020, is designed to enhance the company's financial flexibility during a period of considerable uncertainty, particularly in light of the emerging COVID-19 pandemic. The new credit agreement includes standard representations, warranties, and covenants, with financial covenants requiring HCA to maintain a consolidated debt-to-EBITDA ratio not exceeding 6.75 to 1.00. The facility is secured by certain assets of the borrower and subsidiary guarantors, with intercreditor agreements in place to govern the priority of liens on various collateral pools. Notably, in conjunction with this facility, HCA has suspended its share repurchase program and plans to defer certain capital expenditures.
Key Highlights
- 1HCA Healthcare secured a new $2.0 billion 364-day secured term loan facility (Reserve Liquidity Facility) to bolster financial flexibility.
- 2The facility was established on March 19, 2020, and is designed to provide liquidity amidst the evolving COVID-19 pandemic.
- 3The credit agreement includes customary covenants, with a key financial covenant requiring a debt-to-EBITDA ratio of no more than 6.75 to 1.00.
- 4The facility is secured by specific assets of the borrower and its subsidiary guarantors, with a defined priority structure through intercreditor agreements.
- 5HCA has suspended its share repurchase program as part of measures to enhance financial flexibility.
- 6The company also intends to defer certain capital expenditures and implement other operational adjustments.
- 7The filing highlights HCA's operational focus on patient and employee safety, including enhanced screening, visitor controls, and collaboration with health authorities like the CDC.